Integrated personalised diabetes management
iPDM-GO works to improve diabetes care with a programme that rolls out integrated Personalised Diabetes Management in Denmark, enhances that approach with innovative tools and promotes outcomes-based healthcare payment. The goal is to encourage individualised treatment of diabetes, as well as payment systems that reward better healthcare, throughout Europe.
Origins
While the costs associated with chronic diseases continue to rise, many people with diabetes still do not achieve their treatment goals. Personalising diabetes care, by identifying and tailoring services to the unique needs, preferences and circumstances of each individual with diabetes, has been shown to improve the impact of treatment in the PDM-ProValue study programme by Roche Diabetes Care Germany.
Team
iPDM-GO involves a consortium of diverse partners from industry, academia and healthcare administration in Germany, Denmark and the InnoStars regions. Collectively, the team has extensive expertise and skills in clinical practice, computer science, health psychology, health economics, bioinformatics and close-to-market clinical research and development.
The project
The iPDM-GO consortium will implement integrated Personalised Diabetes Management (iPDM), along with an outcomes-based payment model, in a Danish community setting. The goal is to lay groundwork for expanding these concepts to additional European countries. This geographical scaling out to other countries will be guided by a multi-stakeholder advisory board and include a thorough health systems analysis that considers, among other things, market size, ease of access and feasibility.
In parallel, the iPDM-GO consortium will enhance diabetes care by adding a novel patient-assessment tool that captures the unique needs, circumstances and challenges of each person with diabetes, in order to identify the most appropriate solutions and services. Additionally, iPDM-GO will explore new opportunities for leveraging Big Data resources and developing effective educational programmes for health care professionals.
To support the transformation of healthcare from volume-based to value-based, iPDM-GO will develop a healthcare transformation toolkit that guides the implementation of outcomes-based care in European countries.
Impact
iPDM-GO is seeking to make a positive impact on:
- People with diabetes, by delivering personalised solutions and services that improve their ability to manage their disease, and enhance their quality of life.
- People with chronic diseases, by promoting results-oriented healthcare.
- Healthcare systems and payers, by prioritising good results from healthcare services.
Why this is an EIT Health project
iPDM-GO is in keeping with the EIT Health Focus Area of “Care Pathways”, because it seeks to improve care, by making it more results-oriented. The project also aligns with the Focus Area of “Bringing Care Home”, because it encourages an approach that allows people with diabetes to do more to take care of themselves.
External Partners
- Region Sjælland
- City of Copenhagen (Københavns Kommune)
Partners

CLC/InnoStars: Germany
Partner classification: Research
Partner type: Associate Partner
The German Center for Diabetes Research (DZD) brings together experts in the field of translational diabetes research from bench to bedside. The aim of the DZD is to develop novel strategies for successful personalized prevention and treatment of diabetes.
German Center for Diabetes Research - Deutsches Zentrum für Diabetesforschung e.V. (DZD)
German Center for Diabetes Research - Deutsches Zentrum für Diabetesforschung e.V. (DZD) , Ingolstädter Landstr. 1, 85764 Neuherberg, Germany
Key Activities in Research and Developement
Life Sciences, Clinical research
Key Activities in Social Innovation
Healthcare provision
Key Activities in Business Creation
Technology Transfer
Key Activities in Education
Healthcare professional education/training


CLC/InnoStars: Germany
Partner classification: Research
Partner type: Linked/Affiliated Party
As German Research Center for Environmental Health, Helmholtz Zentrum München pursues the goal of developing personalized medical approaches for the prevention and therapy of major common diseases such as diabetes mellitus, allergies and lung diseases. To achieve this, it investigates the interaction of genetics, environmental factors and lifestyle.
Helmholtz Zentrum München - Deutsches Forschungszentrum Für Gesundheit und Umwelt GmbH
Helmholtz Zentrum München - Deutsches Forschungszentrum Für Gesundheit und Umwelt GmbH, Ingolstädter Landstraße 1, 85764 Oberschleißheim, Germany
Key Activities in Research and Developement
Life Sciences, Clinical research
Key Activities in Social Innovation
Healthcare provision
Key Activities in Business Creation
Technology Transfer
Key Activities in Education
Healthcare professional education/training


CLC/InnoStars: Germany
Partner classification: Education, Research
Partner type: Core Partner
Full service Contract Research Organisation positioned by its focus on innovative solutions for people living with obesity, diabetes and diabetes complications. Has been involved in developing nearly all major anti-diabetic compounds and devices in the market today. Dedicated teams for Medical Device development, Regulatory Affairs, and clinical evaluation of diabetes technologies.
Key Activities in Research and Developement
Life Sciences, Clinical research
Key Activities in Corporate Innovation
Pharma, Med Tech, Diagnostics
Key Activities in Social Innovation
Healthcare provision
Key Activities in Business Creation
Business coaching
Key Activities in Education
Entrepreneurship training, Healthcare professional education/training


CLC/InnoStars: Germany
Partner classification: Business, Research
Partner type: Core Partner
Roche is the world's largest biotech company, with medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche also leads in in-vitro diagnostics, tissue-based cancer diagnostics and in-diabetes management.
Roche Diagnostics GmbH
Roche Diagnostics GmbH, Sandhofer Str. 116, 68305 Mannheim, Germany
Key Activities in Research and Developement
Biomedical engineering, Life Sciences, Clinical research
Key Activities in Corporate Innovation
Pharma, Diagnostics
Key Activities in Social Innovation
Healthcare provision
Key Activities in Business Creation
Incubation, Finance & Investment, Business coaching
Key Activities in Education
Healthcare professional education/training


CLC/InnoStars: Scandinavia
Partner classification: Education, Research
Partner type: Core Partner
DTU focuses on engineering sciences and technology and is renowned for its business-orientation in research and education. DTU is a leader in innovation and offers a strong profile within all stages of the innovation chain on campus.
Technical University of Denmark - DTU
Technical University of Denmark - DTU, Anker Engelunds Vej 1, 2800 Kongens Lyngby, Denmark
Key Activities in Corporate Innovation
Med Tech, ICT, Diagnostics, Imaging, Nutrition
Key Activities in Social Innovation
Healthcare provision
Key Activities in Business Creation
Incubation, Technology Transfer, Business coaching
Key Activities in Education
Business Schools, Entrepreneurship training, Technical faculties


CLC/InnoStars: Scandinavia
Partner classification: Municipality / City
Partner type: Associate Partner
The Capital Region employs 40.000 people in the Copenhagen area Hospitals and got a broad interest in environmental health, cross-sector treatment and care, digitalization and "user-driven" innovation.
The Capital Region / Region Hovedstadens
The Capital Region / Region Hovedstadens, Kildegårdsvej 28, 2900 Hellerup, Denmark
Key Activities in Social Innovation
Healthcare provision, Payers
Key Activities in Business Creation
Testing & Validation
Key Activities in Education
Healthcare professional education/training


CLC/InnoStars: Scandinavia
Partner classification: Education, Research
Partner type: Core Partner
With over 40,000 students and more than 9,500 employees, UCPH – founded 1479 – is among the largest comprehensive universities in Europe. It is ranked No. 7 in Europe and no. 39 in the world in the Academic Ranking of World Universities 2015. The University has an international environment where ambitious researchers and students strive for new knowledge and insights. UCPH is placed at the centre of a stimulation entrepreneurial ecosystem in the Greater Copenhagen Area.
University of Copenhagen (UCPH)
University of Copenhagen (UCPH), Universitetsparken 1, 2100 København Ø, Denmark
Key Activities in Corporate Innovation
Pharma, Med Tech, ICT, Diagnostics, Imaging, Nutrition
Key Activities in Social Innovation
Healthcare provision
Key Activities in Business Creation
Testing & Validation
Key Activities in Education
Entrepreneurship training, Medical faculties, Healthcare professional education/training
